Paritaprevir published presentations and documents on DocSlides.
TURQUOISE-II. Phase 3. . Treatment. Naïve and ...
Paritaprevir. -. Ritonavir (. Technivie. ). Prepa...
-Ritonavir. -Ombitasvir . + Dasabuvir) . + RBV in...
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
SAPPHIRE-I. Phase 3. . Treatment. . Naïve. Fel...
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
. and Dasabuvir +/- . RBV in . GT1b. PEARL-II. P...
Paritaprevir. -. Ritonavir. . and . Dasabuvir. ...
-. Ritonavir . and Dasabuvir . + RBV in . GT1. SA...
. and Dasabuvir + RBV in GT1. SAPPHIRE-I. Phase ...
Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...
. + Dasabuvir) + RBV in GT1 . TURQUOISE-I. Phase...
OBV/PTV/r + RBV. Randomisation*. 1 : 1. Open labe...
Updated: . July . 6. , . 2015. Treatment of Hepat...
DSV . placebo. Randomisation*. Partial blind. 1...
≥ 18 years. Chronic HCV infection. Genotype 1. ...
University of Chicago. Chicago, Illinois. Challen...
Prepared by: . Sophie . Woolston. , MD and David H...
Ombitasvir + . Dasabuvir) +/- . RBV in . GT1b. PEA...
Copyright © 2024 DocSlides. All Rights Reserved